Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

3rd Year (Step 2) > Immuno-modulators > Flashcards

Immuno-modulators Flashcards

1
Q

Heparin MOA

A

Cofactor for activation of antithrombin. Decreases thrombin and factor Xa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical use, heparin

A

Immediate anticoagulation for PE, acute coronary syndrome, MI, DVT. Used during pregnancy (doesn’t cross placenta). Follow PTT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Toxicity, heparin

A

Bleeding, thrombocytopenia (HIT), osteoporosis, drug-drug interactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antidote, heparin?

A

Antidote=protamine sulfate (positively-charged, binds negatively-charged drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Enoxaparin, dalteparin

A

Low weight molecular heparins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Low molecular weight heparins (enoxaparin, dalteparin)

A

Heparins that act more on factor Xa, have better bioavailability and longer half life. Can be given subQ and no lab monitoring necessary. Not easily reversible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Heparin induced thrombocytopenia (HIT)

A

Development of IgG abs against heparin bound to platelet factor 4 (PF4). Antibody-heparin PF4 complex activates platelets–>thrombosis and thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lepirudin, bivalirudin

A

Derivatives of hirudin, the anticoagulant used by leeches; inhibit thrombin. Alternative to heparin for anticoagulating patients with HIT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Warfarin MOA

A

Interferes with normal synthesis and gamma carboxylation of vitamin K dependent clotting factors II, VII, IX and X and proteins C and S. Metabolized by cytochrome P-450 pathway. In lab, has effect on extrinsic pathway and increases PT (The EX-PresidenT went to war(farin)).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Use, warfarin

A

Used in chronic anticoagulation. Not used in pregnant women because can cross the placenta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PT/INR values, warfarin

A

What labs should be followed during warfarin ttmt?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Toxicity, warfarin

A

Bleeding, teratogenic, skin/tissue necrosis, drug-drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Reversal of warfarin

A

Reversal: vitamin K
Rapid reversal of severe overdose: fresh frozen plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alteplase

A

A thrombolytic, tPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Reteplase

A

A thrombolytic, rPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tenecteplase

A

Thrombolytic, TNK-tPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Alteplase, reteplase, tenecteplase

A

Name the thrombolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Thrombolytics

A

Directly or indirectly aid conversion of plasminogen to plasmin, which cleaves thrombin and fibrin clots. Increased PT and PTT, no change in platelet count.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Uses of thrombolytics?

A

Uses: Early MI, early ischemic stroke, direct thrombolysis of severe PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Toxicity, thrombolytics?

A

Toxicity=bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Ttmt of toxicity, thrombolytics?

A

Ttmt of toxicity=aminocaproic acid (an inhibitor of fibrinolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Aspirin, MOA

A

Irreversibly inhibits COX1 and 2 via covalent acetylation. Platelets can’t make new enzyme, so effect lasts until new platelets are made. Increases bleeding time, decreases TXA2 and prostaglandins. No effect on PT or PTT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Clinical use, aspirin

A

Use: antipyretic, analgesic, anti-inflammatory, antiplatelet (decreased aggregation).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Toxicity, aspirin

A

Toxicity: gastric ulceration, tinnitus (CN VIII). Chronic use can lead to acute renal failure, interstitial nephritis, and upper GI bleeding. Reye’s syndrome in children with viral infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What does OD on aspirin cause

A

OD causes respiratory alkalosis and metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

ADP receptor inhibitors?

A

Clopidogrel, ticlopidine, prasugrel, ticagrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

MOA, ADP receptor inhibitors?

A

Inhibit platelet aggregation by irreversibly blocking ADP receptors (ADP its receptor on surface of platelet causes GP IIb/IIIa insertion on the membrane, receptor for fibrinogen). Inhibits fibrinogen binding by preventing glycoprotein IIb/IIIa from binding to fibrinogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Toxicity, ADP receptor inhibitors (ticlopidine)

A

Toxicity: neutropenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Cilostazol is what type of drug?

A

Phosphodiesterase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Ticlopidine=?

A

ADP receptor inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Prasugrel=?

A

ADP receptor inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Clopidogrel=?

A

ADP receptor inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Ticagrelor=?

A

ADP receptor inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Dipyridamole=?

A

Phosphodiesterase III inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Cilostazol, dipyridamole are this type of drug

A

Phosphodiesterase III inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Abciximab is what type of drug?

A

GP IIb/IIIa inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Eptifibatide=?

A

GP IIb/IIIa inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Tirofiban=?

A

GP IIb/IIIa inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Abciximab, eptifibatide, tirofiban=what type of drugs?

A

GP IIb/IIIa inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Cilostazol, dipyridamole MOA

A

Phosphodiesterase III inhibitor, increase cAMP in platelets, thus inhibiting platelet aggregation; vasodilators.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Clinical use, cilostazol, dipyridamole?

A

Use: Intermittent claudification, coronary vasodilation, prevention of stroke or TIAs (combined with aspirin), angina prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Toxicity, cilostazol, dipyridamole?

A

Tox: nausea, headache, facial flushing, hypotension, abdominal pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

MOA, abciximab, eptifibatide, tirofiban

A

MOA: bind to glycoprotein receptor IIb/IIIa on activated platelets, preventing aggregation. Abciximab made from monoclonal Ab Fab fragments.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Clinical use, abciximab, eptifibatide, tirofiban?

A

Use: acute coronary syndromes, percutaneous transluminal coronary angioplasty.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Toxicity, abciximab, eptifibatide, tirofiban?

A

Toxicity: bleeding, thrombocytopenia

46
Q

Antimetabolites act at what phase in the cell cycle?

A

Act on S phase, antimetabolites

47
Q

Etopiside acts on which phases on cell cycle?

A

Act on S phase, G2 phase

48
Q

Bleomycin acts on which phase of the cell cycle?

A

G2 phase

49
Q

Vinca alkaloids and taxols work at which phase of the cell cycle?

A

M phase

50
Q

Methotrexate, MOA

A

MOA:Folic acid analog that inhibits dihydrofolate reductase, v dTMP, v DNA, and v protein synthesis

51
Q

Methotrexate, clinical use

A

Cancers: leukemias, lymphomas, choriocarcinoma, sarcomas
Non-neoplastic: abortion, ectopic pregnancy, rheumatoid arthritis, psoriasis

52
Q

MTX, toxicity

A

Toxicity: myelosuppression reversible with leucovorin (folinic acid) rescue)
-Macrovesicular Fatty change in Liver
- Mucositis
- Teratogen

53
Q

5-fluorouracil MOA

A

Pyrimidine analog bioactivated to 5F-dUMP, which covalently complexes folic acid. This complex inhibits thymidylate synthase–> vdTMP–>v DNA and v protein synthesis

54
Q

5-fluorouracil uses

A

Uses: Colon cancer, basal cell carcinoma

55
Q

5-fluorouracil toxicity

A

Myelosuppresion which isn’t reversible via leucovorin.
- Photosensitivity

56
Q

Antidote for 5-FU OD?

A

Antidote=thymidine

57
Q

MOA, cytarabine (arabinogfuranosyl cytidine)

A

MOA: pyrimidine analog–>inhibition of DNA polymerase

58
Q

Clinical use, cytarabine

A

Clinical use: leukemias, lymphomas

59
Q

Tox, cytarabine

A

Toxicity: leukopenia, thrombocytopenia, megaloblastic anemia

60
Q

MOA, azathioprine, 6-mercaptopurine (6-MP), and 6-thioguanine (6-TG)

A

MOA: purine (thiol) analogs–>v de novo purine synthesis. Acitvated by HGPRT.

61
Q

Clinical use, azathioprine, 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG)

A

Use: Leukemias

62
Q

Azathioprine, 6-mercaptopurine, and 6-thioguanine toxicity

A

Tox: bone marrow, GI, liver

63
Q

Antitumor antibiotics

A

What do dactinomycin (actinomycin D), doxorubicin, daunorubicin, and bleomycin have in common?

64
Q

Dactinomycin MOA

A

Antitumor abx that intercalates in DNA

65
Q

Dactinomycin clinical use

A

Use: wilm’s tumor, Ewing’s Sarcoma, Rhabdomyosarcoma, & used for childhood tumors (children ACT out)

66
Q

Dactinomycin, toxicity

A

Tox: myelosuppression

67
Q

Doxorubicin, daunorubicin MOA

A

MOA: generate free radicals. Noncovalently intercalate in DNA–>breaks in DNA–>decrease replication

68
Q

Doxorubicin, daunorubicin use

A

Use: solid tumors, leukemias, lymphomas

69
Q

Doxorubicin, daunorubicin tox

A

Tox: cardiotoxicity (dilated cardiomyopathy), Myelosuppression, Alopecia, & toxic to tissues following extravasation

70
Q

Doxorubicin, daunorubicin antidote

A

Dexrazoxane (iron chelating agent), used to prevent cardiotoxicity

71
Q

Bleomycin MOA

A

MOA: induces free radical formation, which causes breaks in DNA strands

72
Q

Bleomycin uses

A

use: testicular cancer, lymphoma

73
Q

Bleomycin tox

A

Tox: pulmonary fibrosis, skin changes. Minimal myelosuppression.

74
Q

Alkylating agents

A

Cyclophosphamide & Ifosfamide, Nitrosureas (carmustine, lomustine, semustine, streptozocin), Busulfan

75
Q

Cyclophosphamide, ifosfamide MOA

A

MOA: covalently X-link (interstrnad) DNA @ guanine N-7. Require bioactivation by liver.

76
Q

Uses, cyclophosphamide, ifosfamide

A

Uses: solid tumors, leukemia, lymphomas, and some brain cancers.

77
Q

Tox, cyclophosphamide, ifosfamide

A

Tox: Myelosuppression & Hemorrhagic cystitis

78
Q

Mesna (thiol group binds toxic metabolite)

A

Substance that can be used to prevent hemorrhagic cystitis caused by cyclophosphamide, ifosfamide

79
Q

Nitrousoureas

A

Carmustine, lomustine, semustine, streptozocin are?

80
Q

MOA, nitrousureas

A

MOA: require bioactivation, cross BBB–>CNS

81
Q

Uses, nitrousureas

A

Uses: brain tumors (including glioblastoma multiforme)

82
Q

Toxicity, nitrousureas?

A

Tox: CNS toxicity (dizziness, ataxia)

83
Q

MOA, busulfan

A

MOA: alkylates DNA

84
Q

Uses, busulfan

A

Uses: CML, also used to ablate pt’s bone marrow before bone marrow transplantation.

85
Q

Toxicity, busulfan:

A

Tox: pulmonary fibrosis, hyperpigmentation

86
Q

Microtubule inhibitors

A

Vincristine, vinblastine, Paclitaxel & other taxols

87
Q

MOA: vincristine, vinblastine

A

MOA: alkaloids that bind to tubulin in M phase and block polymerization of microtubules so that mitotic spindle cannot form “Microtbules are the VINes of your cells

88
Q

Tox, vincristine

A

Tox: neurotoxicity (areflexia, peripheral neuritis), paralytic ileus

89
Q

Tox, vinblastine

A

Tox: bone marrow suppress (Vinblastine BLASTS Bone marrow)

90
Q

MOA, paclitaxel, other taxols

A

MOA: hyperstabilize polymerized microtubules in M phase so that mitotic spindle cannot break down (anaphase cannot occur). “it is TAXing to stay polymerized”

91
Q

Toxicity, paclitaxel and other taxols

A

Tox: myelosuppression and hypersensitivity

92
Q

MOA, cisplatin and carboplatin

A

MOA: cross-link DNA

93
Q

Tox, cisplatin and carboplatin

A

Tox: nephrotoxicity and acoustic nerve damage.

94
Q

Amifostine (free radical scavenger) and chloride diuresis

A

How to prevent nephrotoxicity with cisplatin and carboplatin?

95
Q

MOA, etopiside, teniposide

A

MOA: inhibit topoisomerase II–>increase DNA degradation

96
Q

Tox, etopiside, teniposide

A

Tox: myelosuppression, GI irritation, alopecia

97
Q

MOA, hydroxyurea

A

MOA: inhibits ribonucleotide reductase–>v DNA Synthesis (S phase specific)

98
Q

Tox, hydroxyurea

A

TOx: bone marrow suppression, GI upset

99
Q

MOA, prednisone, prednisolone

A

MOA: may trigger apoptosis, may even work on non-dividing cells

100
Q

Toxicity, prednisone, prednisolone

A

Tox: Cushing-like sx, immunosuppression, cataracts, acne, osteoporosis, htn, peptic ulcers, hyperglycemia, psychosis

101
Q

MOA: tamoxifen, raloxifene

A

MOA: SERMs, receptor antagonists in breast and agonists in bone. Block the binding of estrogen to estrogen receptor-positive cells.

102
Q

Toxicity, tamoxifen

A

Tox: partial agonist in endometrium, which increases the risk of endometrial cancer; hot flashes

103
Q

Tox, raloxifene

A

Tox: no increase in endometrial CA because it’s an endometrial antagonist

104
Q

Trastuzumab (Herceptin) MOA

A

MOA: monoclonal Ab vs HER-2 (c-erb B2), a tyrosine kinase. Helps kill breast cancer cells that overexpress HER-2, possibly through antibody-dependent cytotoxicity.

105
Q

Toxicity, trastuzumab

A

Tox: cardiotoxicity

106
Q

MOA, Imatinib (gleevec)

A

MOA: Philadelphia chromosome bcr-abl tyrosine kinase inhibitor

107
Q

Uses, imatinib

A

Use: CML, GI stromal tumors

108
Q

Tox, imatinib

A

Fluid retention=tox

109
Q

Rituximab MOA

A

MOA: monoclonal Ab vs. CD20, which is found on most B cell neoplasms

110
Q

Vemurafenib MOA

A

MOA: small molecule inhibitor of forms of the B-Rag kinase with the V600E mutation.

111
Q

Vemurafenib use

A

Use: metastatic melanoma

112
Q

Bevacizumab MOA

A

MOA: monoclonal ab vs VEGF. Inhibits angiogenesis.

3rd Year (Step 2) (44 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions